Meda AB

Meda AB

Meda AB

Overview
Date Founded

1999

Headquarters

Pipers väg 2A,Solna, Stockholm 170 73

Type of Company

Private

Employees (Worldwide)

4,156

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Biotechnology
Advertising & Marketing

Company Description

Meda AB engages in the research, development, manufacture, and sale of pharmaceutical and medical products. It offers respiratory, dermatology, pain and inflammation, consumer healthcare, and over-the-counter products. The company was founded by Gert Lennart Perlhagen in 1999 and is headquartered in Solna, Sweden.

Website
Contact Data
Trying to get in touch with decision makers at Meda AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Executive Vice President Business Development/Legal & IP

Executive Vice President, Global Marketing

Executive Vice President Region East

Executive Vice President Region West

Executive Vice President, Scientific Affairs

Executive Vice President-Human Resources & Information Technology

Executive Vice President, Supply Chain

Executive Vice President Global Marketing

Vice President Corporate Strategy & M&A

Board of Directors

Secretary at Meda AB

Vice Chairman-Management Board at Celon Pharma SA

Secretary & Director at Mylan Pharma UK Ltd.

Treasurer & Senior Vice President at Visa, Inc.

Paths to Meda AB
Potential Connections via
Relationship Science
You
Meda AB
Recent Transactions
Details Hidden

Mylan NV, Mylan Consumer Healthcare, Inc. purchase Prophase Labs, Inc. /Cold-Eeze Business from ProPhase Labs Inc.

Details Hidden

Mylan NV purchases Meda AB

Details Hidden

The Riverside Company, Riverside Partners LLC purchase Euromed SA - Spain from Meda AB

Transaction Advisors
Investment Advisor

Advised onMylan NV purchases Meda AB

Legal Advisor

Advised onMeda AB purchases Acton Pharmaceuticals, Inc. from Sequoia Capital

Legal Advisor

Advised onMeda AB purchases Valeant Pharmaceuticals Intl/Western & Eastern Europe Ops from Valeant Pharmaceuticals International Corp.

Legal Advisor

Advised onMeda AB purchases Valeant Pharmaceuticals Intl/Western & Eastern Europe Ops from Valeant Pharmaceuticals International Corp.

Legal Advisor

Advised onMeda AB purchases Rottapharm SpA

Legal Advisor

Advised onMeda AB purchases MEDA Pharma GmbH & Co. KG from Advent International Corp.

Clients

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.

Bukwang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include gastrointestinal, central nervous system, metabolic drugs and others such as houlsehold suppiles and gift sets. The company was founded on October 17, 1960 and is headquartered in Seoul, South Korea.

Suppliers
Almirall SA Wholesale: Consumer Non-Durables/Sundries | Barcelona, Spain

Almirall SA engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The company operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Uluru Inc. Pharmaceuticals | Addison, TX

ULURU Inc. is a pharmaceutical company, which engages in the development and commercialization of wound care and muco-adhesive film products. It operates through Nanoflex Technology: Altrazeal and Transmucosal Drug Delivery: OraDisc. The company was founded in 1987 and is headquartered in Addison, TX.

Mylan NV Pharmaceuticals | Hatfield, United Kingdom

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Meda AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Meda AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Meda AB.